Mefitel film for radiation dermatitis: it works, why not?

Published Date: 13 Mar 2023

According to the results of a phase 3 trial, the use of silicone film before radiotherapy can reduce the incidence of radiodermatitis, so why not use it?

Read Full News

Latest News

Shingles Recurrence or Something Worse?

Bedside skin punch biopsy proved crucial

Skin Problems, Kidney Complaints, and Venous Issues Spike During Heat Waves

Study suggests attention to heat-related problems besides heat stroke

First Oral Option for Dermatomyositis Gets FDA Green Light

Brepocitinib significantly improved overall symptom status in a phase III trial

A Call to End Routine Laboratory Monitoring for Patients on Isotretinoin

Streamlined testing still overkill given lack of evidence for hepatotoxicity, pancreatitis

As GLP-1 Use Expands Into Dermatology, So Do the Medicolegal Implications

Off-label indications, use of compounded products could increase liability exposure

Risk of Paradoxical Hidradenitis Suppurativa in Psoriasis Varies by Biologic Agent

Infliximab and adalimumab had the highest risk, risankizumab and guselkumab the lowest

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Latest News

Bedside skin punch biopsy proved crucial

Study suggests attention to heat-related problems besides heat stroke

Brepocitinib significantly improved overall symptom status in a phase III trial

Streamlined testing still overkill given lack of evidence for hepatotoxicity, pancreatitis

Off-label indications, use of compounded products could increase liability exposure

Infliximab and adalimumab had the highest risk, risankizumab and guselkumab the lowest

News All Time

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

Fear of Relapse Burdens Patients With Vitiligo

Nearly half of patients with vitiligo who achieve repigmentation fear losing treatment gains, with relapse-related anxiety affecting psychological well-being even when skin improvement is maintained.

Adding IVIG to Prednisone Boosts Outcomes in IIMs

IVIG plus high-dose prednisone leads to improved disease activity and a faster response in newly diagnosed idiopathic inflammatory myopathies, but clotting remains a concern.

Smoke Exposure Tied to HS Risk in Children and Teens

Both passive and active exposure were associated with increased odds of diagnosis in pediatric and adolescent patients with hidradenitis suppurativa, a study reports.

A Decade After Mercury Ban, Toxic Skin Bleachers Still Offered on Top Retailers' Websites

(Removes errant quote marks in paragraph 14)

Pennsylvania Measles-associated Deaths Climb to Four as Outbreak Grows

The Pennsylvania Department of Health on Tuesday reported two more measles-associated deaths, both in unvaccinated individuals, bringing the state's total fatalities linked...

FDA Grants Priority Review to Zasocitinib for Psoriasis

Zasocitinib is also being evaluated in phase 3 studies for psoriatic arthritis and in phase 2 studies for Crohn’s disease, ulcerative colitis, vitiligo, and hidradenitis suppurativa.

Serious Infections Lower With Anifrolumab in CLE Patients

Anifrolumab, approved for systemic lupus, is currently being evaluated in a phase 3 study in patients with cutaneous lupus erythematosus.

COVID, 6 Years on: The Pandemic’s Long Clinical Shadow

Although acute COVID is generally less severe today, long COVID, limited treatment options, and ongoing controversy still define the pandemic’s aftermath.

Prior Keratinocyte Carcinoma Tied to Mucosal Melanoma

A history of keratinocyte carcinoma was associated with more than four times the odds of mucosal melanoma, study reports.

Trust in Measles Vaccines Falls in US, Reuters Ipsos Poll Finds

Americans' trust in vaccines for deadly childhood diseases including measles has fallen in recent years, a new Reuters/Ipsos poll found, a troubling sign for the country as...

Arizona Accuses L'Oreal Of Concealing Cancer Risks Linked to Hair Relaxers

Arizona has sued L'Oreal SA and its U.S. subsidiary, alleging the cosmetics company hid evidence that its hair relaxer products could cause cancer ⁠in women, as it faces...

Pembrolizumab Benefits Persist in Cervical Cancer

After 5 years of follow-up, pembrolizumab plus chemotherapy continues to demonstrate sustained survival advantages in patients with persistent, recurrent, or metastatic cervical cancer.

Combo Therapy May Help in Systemic Autoinflammatory Diseases

Patients with systemic autoinflammatory diseases refractory to standard treatments may show clinical improvements when treated with combinations of biologics and JAK inhibitors.

Criteria for Prescribing Testosterone: Who Qualifies?

A Brazilian multidisciplinary consensus sets thresholds for the diagnosis and treatment while emphasizing symptom assessment, repeated testing, and attention to the underlying causes.

Adjuvant Anti-PD-1 Boosts OS in Matched Melanoma Cases

Adjuvant anti-PD-1 therapy is tied to higher 5-year overall survival in patients with stage III melanoma in a matched analysis, but the population-level benefit remains unproven, a Danish study finds.

Recommended News For You

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

Recently released national data on drug use and abuse among Americans.

Fixed-Duration Combo Shows Promise for Relapsed MCL

Early, virtual palliative care feasible for advanced lung cancer

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

Recommended Articles For You

The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025 

The Science Behind Imatinib: How It Targets Cancer Cells  

Multidisciplinary Lessons from a Cancer of Unknown Primary 

Transformative Approaches in Hematology for Healthcare Excellence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

2.

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

3.

Fixed-Duration Combo Shows Promise for Relapsed MCL

4.

Could Burnout Become the Employer’s Responsibility?

5.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

1.

Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts

2.

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective

3.

The importance of understanding normal serum osmolality

4.

Biomarkers of Hematopoietic Reserve During Repeated Physiological Stress

5.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

2.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

4.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

5.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot